Robert Burns's
Stock Forecasts
5.88%
1/17 win trades
Price targets by Robert Burns
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Nurix Therapeutics, Inc. NRIX | 11 months ago | $30 203.33% upside | $25.19 | StreetInsider | |
 Zymeworks Inc. ZYME | about 1 year ago | $12 -14.89% downside | $12.5 | TheFly | Previous targets (0) |
 Exelixis, Inc. EXEL | about 1 year ago | $29 -22.74% downside | $26.52 | StreetInsider | Previous targets (0) |
 Immix Biopharma, Inc. IMMX | about 1 year ago | $7 204.34% upside | $1.98 | TheFly | Previous targets (0) |
 Replimune Group, Inc. REPL | over 1 year ago | $17 223.19% upside | $7.11 | TheFly | Previous targets (0) |
 Tango Therapeutics, Inc. TNGX | over 1 year ago | $13 83.09% upside | $6.91 | TheFly | Previous targets (0) |
 Black Diamond Therapeutics, Inc. BDTX | over 1 year ago | $11 316.66% upside | $5.44 | TheFly | Previous targets (0) |
 Y-mAbs Therapeutics, Inc. YMAB | over 1 year ago | $22 157.91% upside | $12.87 | TheFly | Previous targets (0) |
 ADC Therapeutics SA ADCT | over 1 year ago | $8 147.67% upside | $4.45 | StreetInsider | Previous targets (0) |
 Kronos Bio, Inc. KRON | over 1 year ago | $2.25 155.68% upside | $1.03 | StreetInsider | Previous targets (0) |
 Nuvation Bio Inc. NUVB | over 1 year ago | $8 191.97% upside | $3.97 | StreetInsider | Previous targets (0) |
 ORIC Pharmaceuticals, Inc. ORIC | over 1 year ago | $21 120.35% upside | $14.59 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Olga Smolentseva
Bryan Garnier & Co Ltd
100%
win rate
Covering:
Andrew Ang
UBS
100%
win rate
Covering:
Daina Graybosch
Leerink Partners
50%
win rate
Covering:
Emmanuel Papadakis
Deutsche Bank
28.57%
win rate
Christopher Liu
Leerink Partners
25%
win rate
Yifeng Liu
HSBC
25%
win rate